Literature DB >> 7116656

Arterial compliance in systolic hypertension.

F H Messerli, H Ventura, G G Aristimuno, D H Suarez, G R Dreslinski, E D Frohlich.   

Abstract

Arterial compliance as estimated by pulse wave velocity and the pulse pressure/stroke volume index was evaluated in 27 normotensive subjects, 21 patients with established, and 18 patients with systolic essential hypertension. Pulse wave velocity was elevated to the same degree in both hypertensive groups when compared to the normotensive controls. The pulse pressure/stroke volume index was higher in essential hypertension than in normotensive subjects and even higher in patients with systolic hypertension. It is concluded that both indices are useful clinical tools to determine arterial compliance. Systolic hypertension does not always indicate stiffening of the arterial tree, but may result from a high stroke volume in the presence of a normal arterial compliance.

Entities:  

Mesh:

Year:  1982        PMID: 7116656     DOI: 10.3109/10641968209060772

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  3 in total

1.  The use of nitroprusside to characterize aortic pressure-diameter relationships.

Authors:  J J Ferguson; S Momomura; P Sahagian; M J Miller; R G McKay
Journal:  Tex Heart Inst J       Date:  1989

2.  Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease.

Authors:  R H Mohiaddin; S R Underwood; H G Bogren; D N Firmin; R H Klipstein; R S Rees; D B Longmore
Journal:  Br Heart J       Date:  1989-08

3.  Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with type 2 diabetes mellitus.

Authors:  Nobuko Kitagawa; Emi Ushigome; Noriyuki Kitagawa; Hidetaka Ushigome; Isao Yokota; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Diab Vasc Dis Res       Date:  2022 May-Jun       Impact factor: 3.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.